Telomir Pharmaceuticals, Inc. (TELO) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $1.43M | +109.7% |
| 2024 | $681.0K | -49.0% |
| 2023 | $1.34M | +35.5% |
| 2022 | $986.0K | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $1.43M | +109.7% |
| 2024 | $681.0K | -49.0% |
| 2023 | $1.34M | +35.5% |
| 2022 | $986.0K | — |